Skip to main content
Log in

Stability of plasma amiodarone levels during chronic oral therapy

  • Arrhythmias
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

The variability of plasma amiodarone levels in 51 patients receiving chronic oral therapy over 4–53 (median 19) months was examined; 3–14 (median 5) plasma samples were obtained. After a loading dose, most patients received either 200mg or 400mg a day. Mean plasma amiodarone concentration was 1.2±0.6mg/l and mean plasma desethylamiodarone concentration, was 1.2±0.5mg/l. No relationship was seen between height and weight and plasma concentrations. Dose was a significant predictor of plasma level (p<0.01) although it was a poor predictor of steady state amiodarone concentration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Haffajee CI, Love JC, Canada AT et al. Clinical pharmacokinetics and efficacy of aminodarone for refractory tachyarrhythmias.Circulation 1983;67:1347–1355.

    PubMed  Google Scholar 

  2. Heger JJ, Prystowsky EN, Zipes DP. Relationships between amiodarone dosage, drug concentrations and adverse side effects.Am Heart J 1983;106:931–935.

    PubMed  Google Scholar 

  3. Staubli M, Bircher J, Caleazzi RL, et al. Serum concentrations of amiodarone during long term therapy: Relation to dose efficacy and toxicity.Eur J Clin Pharm 1983;24:485–494.

    Google Scholar 

  4. Holt DW, Tucker GT, Jackson PR, et al. Amiodarone pharmacokinetics.Am Heart J 1983;106:840–847.

    PubMed  Google Scholar 

  5. Andreasen F, Agerback H, Bjerregard P, et al. Pharmacokinetics of amiodarone after intravenous and oral administration.Eur J Clin Pharm 1981;19.:2–9.

    Google Scholar 

  6. Storey GCA, Holt DW. High performance liquid chromatographic measurement of amiodarone and its desethylmetabolite in plasma or serum at the concentrations attained following a single 400 mg dose.J Chromatogr 1982;245:377–380.

    PubMed  Google Scholar 

  7. Schwartz JB, Keefe DL, Kirsten E, et al. Prolongation of verapamil elimination kinetics during chronic oral administration.Am Heart J 1982;104:198–203.

    PubMed  Google Scholar 

  8. Bauer LA, Brown T, Gibaldi M, et al. Influence of long-term infusions on lidocaine kinetics.Clin Pharmacol Ther 1982; 31:433–439.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robinson, K., Johnston, A., Walker, S. et al. Stability of plasma amiodarone levels during chronic oral therapy. Cardiovasc Drug Ther 4, 529–530 (1990). https://doi.org/10.1007/BF01857765

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01857765

Key Words

Navigation